Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review

Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review

Caffeine is the most used central nervous system stimulant drug to date. Many studies have shown the association of caffeine with bone remodeling, urinary calcium excretion, kidney stones, acid peptic disease, and the development of cancer. However, there has been very little research exploring the...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) Vol. 12; no. 8; p. e9958
Main Authors: Reddy, Mithun K, Murthy, Pooja M, Elsayed, Sarah M, Hussain, Mir Mehdi, Robert, Chris A
Format: Journal Article
Language:English
Published: United States Cureus 23-08-2020
Subjects:
Endocrinology/Diabetes/Metabolism
Internal Medicine
Oncology
parathyroid gland adenoma
caffeine
parathyroid cancer
primary hyperparathyroidism
caffeine treatment
hyperparathyroidism treatment
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Caffeine is the most used central nervous system stimulant drug to date. Many studies have shown the association of caffeine with bone remodeling, urinary calcium excretion, kidney stones, acid peptic disease, and the development of cancer. However, there has been very little research exploring the association between caffeine use and parathyroid gland disorders. We shed light on the possible connection between caffeine and parathyroid adenomas, as suggested in the literature.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.9958